I think the point is that the company would do a study using methodology A to determine the efficacy of their drug. If the results were favorable, then they would register a study using methodology A and publish the results. If the results from using methodology A the first time were bad, then they would move on to mthodology B and give it a whirl. This way they could do many studies using different methodologies but only register and publish the favorable ones.
Slashdot Mirror
I think the point is that the company would do a study using methodology A to determine the efficacy of their drug. If the results were favorable, then they would register a study using methodology A and publish the results. If the results from using methodology A the first time were bad, then they would move on to mthodology B and give it a whirl. This way they could do many studies using different methodologies but only register and publish the favorable ones.